Markku Saloheimo

This inventor holds 25 USPTO granted patents and 15 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Filamentous Fungi. Top assignees: Glykos Finland Oy, Danisco US Inc., Genencor International, Inc.. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markku Saloheimo. Retrieved from https://idiyas.com/inventor/markku-saloheimo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 15)

% Patents Active = 76.0

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

Espoo, FI (2016 - 2017)
Helsinki, FI (2002 - 2023)

Company Filing History:

Genencor International, Inc.

patents

4. 2 out of 51

Teknologian Tutkimuskeskus Vtt

patents

5. 2 out of 238

Teknologian Tutkimuskeskus VTT Oy

patents

6. 2 out of 152

Valtion Teknillinen Tutkimuskeskus

patents

7. 2 out of 16

Vtt Technical Research Centre of Finland Ltd

patents

8. 1 out of 23

Genecor International, Inc.

patents

9. 1 out of 29

Novartis International Pharmaceutical, Ltd.

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

Areas of Expertise:

Protease Deficiency

Filamentous Fungi

Glycoprotein Production

O-mannosyltransferase

Polypeptides

Esterase Activity

Fusion Enzymes

Xylanase

Recombinant Eukaryotic Cells

Tyrosinase Activity

Microbial Swollenin

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827891 - Protease deficient filamentous fungal cells and methods of use thereof (2023-11-28),

2. 11180767 - Protease deficient filamentous fungal cells and methods of use thereof (2021-11-23),

3. 10988791 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2021-04-27),

4. 10876103 - Protein production in filamentous fungal cells in the absence of inducing substrates (2020-12-29),

5. 10731168 - Protease deficient filamentous fungal cells and methods of use thereof (2020-08-04),

6. 10724063 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2020-07-28),

7. 10724013 - O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof (2020-07-28),

8. 10544440 - Multiple protease deficient filamentous fungal cells and methods of use thereof (2020-01-28),

9. 10513724 - Production of glycoproteins with mammalian-like N-glycans in filamentous fungi (2019-12-24),

10. 10435731 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2019-10-08),

11. 10240159 - Protease deficient filamentous fungal cells and methods of use thereof (2019-03-26),

12. 9783793 - Polypeptides and active fragments of polypeptides having at least one esterase activity (2017-10-10),

13. 9695454 - Production of fucosylated glycoproteins (2017-07-04),

14. 9695430 - Method for improved protein production in filamentous fungi (2017-07-04),

15. 9567596 - Protease deficient filamentous fungal cells and methods of use thereof (2017-02-14),

Title: Innovations by Markku Saloheimo: A Pioneering Inventor from Helsinki

Introduction: Markku Saloheimo, an accomplished inventor based in Helsinki, Finland, has made significant contributions to the field of biotechnology, particularly in the development of novel methods for producing heterologous proteins. With a remarkable portfolio of 25 patents, Saloheimo's work reflects his dedication to pushing the boundaries of scientific innovation.

Latest Patents: Markku Saloheimo's latest patents include groundbreaking technologies related to protease deficient filamentous fungal cells. These patents focus on the compositions and methods useful for the production of heterologous proteins in filamentous fungal cells, paving the way for advancements in biotechnology and industrial applications.

Career Highlights: Saloheimo's career has been marked by his roles at notable companies such as Glykos Finland Oy and Genencor International, Inc. His experience at these organizations has equipped him with a unique skill set, allowing him to lead and contribute to cutting-edge research and innovation in protein production.

Collaborations: Throughout his career, Markku Saloheimo has collaborated with esteemed colleagues including Ann Westerholm-Parvinen and Anne Huuskonen. These partnerships have fostered an environment of creativity and shared knowledge, essential for driving successful innovations in their projects.

Conclusion: Markku Saloheimo's impressive list of patents and collaborations highlights his status as a leading inventor in the biotechnology sector. His work not only advances scientific understanding but also has practical applications that can significantly impact various industries. As he continues to innovate, the scientific community eagerly anticipates his future contributions to the field.

Profile summary based on public USPTO records.